Invokana Linked To Increased Risk Of Leg, Foot & Toe Amputations
Current Invokana patients should watch for pain and tenderness in the feet, legs or toes, while physicians are instructed to screen prospective patients for factors that increase the risk of amputation.
Invokana Amputation Lawsuits
Hundreds of type 2 diabetes patients have already filed Invokana lawsuits against Janssen Pharmaceutical, the drug’s manufacturer and a subsidiary of global giant Johnson & Johnson. Today, more than 850 lawsuits are consolidated in the US District Court of New Jersey, claiming Invokana causes multiple severe complications, including diabetic ketoacidosis and kidney failure. With new medical evidence confirming a link between Invokana and amputations, legal observers believe that hundreds of other type 2 diabetes patients may also be able to file suit.
Increased Risk For Foot & Leg Amputations
New statistical analyses confirm that patients taking Invokana, Invokamet or Invokamet XR are around twice as likely to require leg and foot amputations than patients taking a placebo.
Alarmed by these recent findings, experts at the US Food & Drug Administration have now formally warned patients of Invokana’s newly-identified risk. On May 16, 2017, the FDA issued an urgent safety announcement, citing new data from two major clinical trials that investigated the drug’s potential dangers for eight years.
CANVAS & CANVAS-R
The risk for limb amputations, however, only became conclusive once these trials, known in medical circles as CANVAS and CANVAS-R, were completed in July 2017.
Want to share this infographic on your site? Use the code below, but please Continue reading